Mitsubishi Ufj Trust & Banking Corp Abb Vie Inc. Transaction History

Mitsubishi Ufj Trust & Banking Corp

$43.3 Billion
Q1 2024

A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 1,567,627 shares of ABBV stock, worth $269 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares

1,567,627

Previous 1,612,709 2.8%

Holding current value

$269 Million

Previous $250 Million 14.22%

% of portfolio

0.66%

Previous 0.59%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $7.21 Million - $8.21 Million	-45,082 Reduced 2.8%	1,567,627 $285 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $8.3 Million - $9.35 Million	60,311 Added 3.89%	1,612,709 $250 Million
Q3 2023 Nov 09, 2023	SELL	$133.59 - $154.65 $16 Million - $18.5 Million	-119,821 Reduced 7.17%	1,552,398 $231 Million
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $2.89 Million - $3.59 Million	21,789 Added 1.32%	1,672,219 $225 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $3.14 Million - $3.62 Million	-21,716 Reduced 1.3%	1,650,430 $263 Million

Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $14.4 Million - $17.3 Million	104,286 Added 6.65%	1,672,146 $270 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $2.28 Million - $2.61 Million	16,986 Added 1.1%	1,567,860 $210 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $17.9 Million - $22.7 Million	129,928 Added 9.14%	1,550,874 $238 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $7.44 Million - $9.23 Million	-56,376 Reduced 3.82%	1,420,946 $230 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $2.09 Million - $2.64 Million	-19,431 Reduced 1.3%	1,477,322 $200 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $8.33 Million - $9.46 Million	-78,326 Reduced 4.97%	1,496,753 $161 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $29.9 Million - $33.3 Million	-284,029 Reduced 15.28%	1,575,079 $177 Million
Q1 2021 May 12, 2021	SELL	$102.3 - $112.62 $16 Million - $17.6 Million	-156,245 Reduced 7.75%	1,859,108 $201 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $11.3 Million - $15.3 Million	140,718 Added 7.51%	2,015,353 $216 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $10.3 Million - $12 Million	119,477 Added 6.81%	1,874,635 $164 Million
Q2 2020 Sep 11, 2020	BUY	$73.37 - $98.18 $16.7 Million - $22.3 Million	227,486 Added 14.89%	1,755,158 $172 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $6.39 Million - $8.55 Million	-87,077 Reduced 5.39%	1,527,672 $172 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $15.6 Million - $23.7 Million	242,194 Added 17.65%	1,614,749 $123 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.62 Million - $2.03 Million	22,452 Added 1.66%	1,372,555 $122 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $7.98 Million - $9.6 Million	126,780 Added 10.36%	1,350,103 $101 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $1.08 Million - $1.39 Million	-16,503 Reduced 1.33%	1,223,323 $85.6 Million
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $5.19 Million - $6.11 Million	-67,276 Reduced 5.15%	1,239,826 $99.1 Million
Q4 2018 Feb 12, 2019	BUY	$77.85 - $96.01 $182,636 - $225,239	2,346 Added 0.18%	1,307,102 $121 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $173 Million - $193 Million	-1,948,302 Reduced 59.89%	1,304,756 $123 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $12.5 Million - $14.8 Million	-138,958 Reduced 4.1%	3,253,058 $301 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $8.73 Million - $11.7 Million	-94,833 Reduced 2.72%	3,392,016 $321 Million
Q4 2017 Feb 09, 2018	SELL	$89.56 - $98.21 $1.88 Million - $2.06 Million	-21,021 Reduced 0.6%	3,486,849 $337 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $245 Million - $313 Million	3,507,870	3,507,870 $312 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Account

Mitsubishi Ufj Trust & Banking Corp Abb Vie Inc. Transaction History